Bispecific Antibodies: A New Era of Treatment for Multiple Myeloma

Despite the introduction of novel agents such as proteasome inhibitors, immunomodulatory drugs, and autologous stem cell transplant, multiple myeloma (MM) largely remains an incurable disease. In recent years, monoclonal antibody-based treatment strategies have been developed to target specific surf...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Xiang, Einsele, Hermann, Danhof, Sophia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408718/
https://www.ncbi.nlm.nih.gov/pubmed/32659909
http://dx.doi.org/10.3390/jcm9072166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408718/
https://www.ncbi.nlm.nih.gov/pubmed/32659909
http://dx.doi.org/10.3390/jcm9072166

Ejemplares similares